Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
about
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel diseaseLive-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryOptimization of Ultrasound-mediated Anti-angiogenic Cancer Gene Therapy.Effect of nonviral plasmid delivered basic fibroblast growth factor and low intensity pulsed ultrasound on mandibular condylar growth: a preliminary study.A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapyDouble-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review)New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.Bacteria-mediated disease therapy.Emerging biotechnological strategies for non-viral antiangiogenic gene therapy.A novel microfluidic co-culture system for investigation of bacterial cancer targeting.Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation.Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.Isolation and screening of proangiogenic and antiangiogenic metabolites producing rare actinobacteria from soil.A microfluidic device for studying chemotaxis mechanism of bacterial cancer targeting.The role of bacteria in cancer therapy - enemies in the past, but allies at present.
P2860
Q26777414-B4F85F92-8F3D-4D15-912A-C4108ADA5BAAQ28084076-0A28F030-01EA-4C0D-B077-255A75D47508Q30385729-4D166D03-5B40-438B-B1E7-8BAB902ADC04Q30436033-92230C43-0F5A-43F8-BD7B-69695AF400E4Q34315760-02275169-2107-495D-83B1-91619EEB5D87Q34385537-2C205830-8EB6-4627-98EB-05AFA594932AQ34427510-AA11EDBA-4120-4336-9B76-10FE089FE11BQ37924090-C80A8A90-A209-4638-907F-A8AE5E423DE3Q37950232-DE6F4BE4-AEBB-405E-98D9-122A80CEB3AAQ38034448-1813A73C-1DB6-4A48-B3DB-36B4CE6F333AQ39142968-3DB0078C-A28D-468E-A1BF-273500DCDADFQ39205186-C00EBBC3-40AD-47F4-8A1C-76BA50E43169Q39365796-4BC2E2E5-8EBC-4B10-9574-F4BA9A9E4DE5Q48330378-2333F267-857B-49DB-8F7C-A48FAC33351EQ52568531-05B901E3-5612-4204-A98B-AC57F66B607EQ53699248-43CE47E9-3541-42E6-9A48-FA16A73B6290
P2860
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
@en
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
@nl
type
label
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
@en
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
@nl
prefLabel
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
@en
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
@nl
P2093
P2860
P356
P1433
P1476
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2010.176
P50
P577
2011-01-13T00:00:00Z